The results provide novel insights into the regulation of SENP3/STAT3/PYCR1 pathway, which has key roles in bladder cancer progression and may aid in identifying new biomarkers or targeted therapies for bladder cancer. Here, PYCR1 is linked to urinary bladder cancer.